293 related articles for article (PubMed ID: 25938762)
41. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
42. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.
Kyle JL; Balsitis SJ; Zhang L; Beatty PR; Harris E
Virology; 2008 Oct; 380(2):296-303. PubMed ID: 18774583
[TBL] [Abstract][Full Text] [Related]
43. Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model.
Callaway JB; Smith SA; Widman DG; McKinnon KP; Scholle F; Sempowski GD; Dittmer DP; Crowe JE; de Silva AM; Ting JP
PLoS One; 2015; 10(8):e0136708. PubMed ID: 26301593
[TBL] [Abstract][Full Text] [Related]
44. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.
Katzelnick LC; Montoya M; Gresh L; Balmaseda A; Harris E
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):728-33. PubMed ID: 26729879
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.
Stein DA; Perry ST; Buck MD; Oehmen CS; Fischer MA; Poore E; Smith JL; Lancaster AM; Hirsch AJ; Slifka MK; Nelson JA; Shresta S; Früh K
J Virol; 2011 Oct; 85(19):10154-66. PubMed ID: 21795337
[TBL] [Abstract][Full Text] [Related]
46. Immune response to dengue virus and prospects for a vaccine.
Murphy BR; Whitehead SS
Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
[TBL] [Abstract][Full Text] [Related]
47. Serotype-specific host responses in rhesus macaques after primary dengue challenge.
Hickey AC; Koster JA; Thalmann CM; Hardcastle K; Tio PH; Cardosa MJ; Bossart KN
Am J Trop Med Hyg; 2013 Dec; 89(6):1043-57. PubMed ID: 24062475
[TBL] [Abstract][Full Text] [Related]
48. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
49. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
[TBL] [Abstract][Full Text] [Related]
50. Infection of bone marrow cells by dengue virus in vivo.
Noisakran S; Onlamoon N; Hsiao HM; Clark KB; Villinger F; Ansari AA; Perng GC
Exp Hematol; 2012 Mar; 40(3):250-259.e4. PubMed ID: 22193689
[TBL] [Abstract][Full Text] [Related]
51. Dengue virus infects the mouse eye following systemic or intracranial infection and induces inflammatory responses.
Norbury AJ; Calvert JK; Al-Shujairi WH; Cabezas-Falcon S; Tang V; Ong LC; Alonso SL; Smith JR; Carr JM
J Gen Virol; 2020 Jan; 101(1):79-85. PubMed ID: 31774391
[TBL] [Abstract][Full Text] [Related]
52. Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection.
Choy MM; Zhang SL; Costa VV; Tan HC; Horrevorts S; Ooi EE
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004058. PubMed ID: 26565697
[TBL] [Abstract][Full Text] [Related]
53. Immunological and Pathological Landscape of Dengue Serotypes 1-4 Infections in Immune-Competent Mice.
Rathore APS; Mantri CK; Tan MW; Shirazi R; Nishida A; Aman SAB; Morrison J; St John AL
Front Immunol; 2021; 12():681950. PubMed ID: 34168651
[TBL] [Abstract][Full Text] [Related]
54. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.
Breitbach ME; Newman CM; Dudley DM; Stewart LM; Aliota MT; Koenig MR; Shepherd PM; Yamamoto K; Crooks CM; Young G; Semler MR; Weiler AM; Barry GL; Heimsath H; Mohr EL; Eichkoff J; Newton W; Peterson E; Schultz-Darken N; Permar SR; Dean H; Capuano S; Osorio JE; Friedrich TC; O'Connor DH
PLoS Pathog; 2019 Aug; 15(8):e1007766. PubMed ID: 31369649
[TBL] [Abstract][Full Text] [Related]
55. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
[TBL] [Abstract][Full Text] [Related]
56. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
[TBL] [Abstract][Full Text] [Related]
57. Antibody-dependent enhancement representing in vitro infective progeny virus titer correlates with the viremia level in dengue patients.
Yamanaka A; Imad HA; Phumratanaprapin W; Phadungsombat J; Konishi E; Shioda T
Sci Rep; 2021 Jun; 11(1):12354. PubMed ID: 34117329
[TBL] [Abstract][Full Text] [Related]
58. Generation and comparative genomics of synthetic dengue viruses.
Goz E; Tsalenchuck Y; Benaroya RO; Zafrir Z; Atar S; Altman T; Julander J; Tuller T
BMC Bioinformatics; 2018 May; 19(Suppl 6):140. PubMed ID: 29745863
[TBL] [Abstract][Full Text] [Related]
59. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
[TBL] [Abstract][Full Text] [Related]
60. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections.
Gallichotte EN; Baric RS; de Silva AM
Adv Exp Med Biol; 2018; 1062():63-76. PubMed ID: 29845525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
